alexa The Role Of Inflammatory Infiltrate In The Assessment Of DCIS | OMICS International
ISSN: 2161-1076

Surgery: Current Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

13th International Conference on Surgical Pathology & Practice
March 27-28, 2017 Madrid, Spain

Shagufta Khan and Nives Zimmermann
University of Cincinnati, USA
Posters & Accepted Abstracts: Surgery Curr Res
DOI: 10.4172/2161-1076.C1.030
Abstract
Incidence of breast Ductal Carcinoma In Situ (DCIS) is on the rise. Previous studies have shown up to 50% of DCIS cases will recur as DCIS or progress to invasive disease; however, robust predictive factors have not been identified. DCIS is associated with inflammatory infiltrate, which varies in amount, distribution and composition. Since the immune system’s response is an important predictor of biologic behavior in cancer of other sites, we hypothesize that the level and/or type of local immune response correlates with more aggressive disease with propensity for recurrence or progression. We identified five patients with DCIS who went on to have disease recurrence, and five control subjects without disease recurrence. Sections were stained with H&E (to assess nuclear grade, necrosis and inflammation score), and immunohistochemistry (CD45, CD3, CD20, CD56, CD68, and CD138; scored for level and distribution of staining). Clinicopathologic correlation was done for disease recurrence, margin status on excision and hormone receptor status on biopsy. There was a variable lymphoplasmacytic infiltrate (LPI) in our cases. When present, this infiltrate is composed of predominantly T cells (CD3-positive cells), followed by B cells (CD20) and plasma cells (CD138) of the 5 patients with recurrence of disease, four had moderate to severe LPI (by H&E and immunohistochemistry); in contrast, only 2 out of 5 without recurrence had moderate, and none had severe, level of infiltrate. Patients with recurrence had higher grade of DCIS, were more likely to be ER/PR negative, and have positive or close margins on lumpectomy when compared to patients without recurrence. Indeed, statistical analysis demonstrated significant positive correlation of amount of CD45-positive cells and DCIS grade (Spearman correlation, r=0.75, P=0.04). Furthermore, ER/PR status and status of margins were significantly associated with disease recurrence (P<0.05); level of LPI and nuclear grade showed a trend but not statistically significant association, presumably due to low number of patients in our study. M-1 macrophages (CD68-positive, arginase-1 negative) were part of the infiltrate; their level and distribution did not correlate with clinical outcomes. In contrast to predicting good prognosis in invasive disease, LPI in DCIS correlates with high nuclear grade and should alert the pathologist and clinician of a possibility of more aggressive disease course.
Biography

Shagufta Khan is currently working as an Assistant Professor for Pathology and Laboratory Medicine Department at University of Cincinnati Medical Center, USA.

Email: khanst@ucmail.uc.edu

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version